| TRADING CENTER |
| The Boston Globe names Cubist to Globe 100's Top Places to Work ‘09 - Business Wire | |
| Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual Healthcare Con... - Business Wire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 56.80 | 0.55 / 0.98% | 10.86 |
| GILD | Gilead Sciences Inc | 46.96 | -0.05 / -0.11% | 18.13 |
| CELG | Celgene Corporation | 55.37 | -0.28 / -0.50% | 66.71 |
| 2008 Revenue: | $433.6 M | Headquarters: Lexington, MA |
| Employees: | 554 | CEO: Michael W. Bonney |
| Net Income: | $169.8 M | Industry: Biotechnology |
| Market Cap: | $982.2 M | Website: www.cubist.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| CBST | 16.80 | -0.19 / -1.12% | 16.99 | 17.05 | 16.71 | Profile Chart News |